Viatris Inc.: Osteoarthritis trials

The registry lists 12 Osteoarthritis studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 3 3Phase 4 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"CompletedNCT03172780Phase 3Results posted
• Efficacy And Safety Of Pregabalin For Pain Following Total Knee ReplacementCompletedNCT00442546Phase 3Results posted
• GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)CompletedNCT00373685Phase 4Results posted
• Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With ArthritisCompletedNCT00141102Phase 4Results posted
• Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"CompletedNCT00139776Phase 4Results posted
• Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee OsteoarthritisCompletedNCT00643799Phase 4
• Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and IbuprofenCompletedNCT00640627Phase 4
• Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and IbuprofenCompletedNCT00638807Phase 4
• Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)CompletedNCT00630929Phase 4
• Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)CompletedNCT00620867Phase 4
• Celebrex Total Knee Arthroplasty StudyTerminatedNCT00359151Phase 4
• Effect Of Celecoxib On Hip Osteoarthritis (OA) ProgressionTerminatedNCT00163241Phase 3